NASDAQ:SNTI

Senti Biosciences Stock Near $1: FDA Signal and Cash Test Put SNTI Back on Watch
····

Senti Biosciences Stock Near $1: FDA Signal and Cash Test Put SNTI Back on Watch

Senti Biosciences shares traded near $1 in U.S. premarket Tuesday after the Memorial Day break, following an FDA update on its SENTI-202 cell therapy. The company reported $8.9 million in cash at March 31 and a $4.2 million quarterly net loss. Senti secured a financing deal for up to $40 million in convertible notes with Celadon Partners. The biotech sector remained weak ahead of the holiday.
May 26, 2026

Stock Market Today

  • Evion Appoints Ex-Ambassador Sinodinos to Drive US Critical Minerals Strategy
    June 1, 2026, 10:21 PM EDT. Evion Group (ASX:EVG) has appointed Arthur Sinodinos, former Australian ambassador to the US, as strategic advisor to boost its US critical minerals initiatives. The move follows Evion's May acquisition of the Carp fluorspar project in Nevada. Sinodinos, with senior government experience, will aid in navigating government relations, funding, and partnerships amid increased US efforts to secure critical minerals essential for industries like semiconductors, defense, and advanced manufacturing. This aligns with the Quad nations' US$20 billion agreement to diversify critical mineral supply chains away from non-market sources. Evion's integrated mining and processing footprint spans the US, Madagascar, and India, positioning it strategically in allied markets.